RESEARCH LIBRARY

Academic Medicine: Volume 99 - Issue 7 - Pages 778-783

This study examined score comparability between in-person and remote proctored administrations of the 2020 Internal Medicine In-Training Examination (IM-ITE) during the COVID-19 pandemic. Analysis of data from 27,115 IM residents revealed statistically significant but educationally nonsignificant differences in predicted scores, with slightly larger variations observed for first-year residents. Overall, performance did not substantially differ between the two testing modalities, supporting the continued use of remote proctoring for the IM-ITE amidst pandemic-related disruptions.

Muscle Nerve, 58: 646-654

The Amyotrophic Lateral Sclerosis (ALS)‐Specific Quality of Life instrument and its revised version (ALSSQOL and ALSSQOL‐R) have strong psychometric properties, and have demonstrated research and clinical utility. This study aimed to develop a short form (ALSSQOL‐SF) suitable for limited clinic time and patient stamina.

Qual Life Res 27, 1711–1720 (2018)

The US Food and Drug Administration (FDA), as part of its regulatory mission, is charged with determining whether a clinical outcome assessment (COA) is “fit for purpose” when used in clinical trials to support drug approval and product labeling. This paper provides a review (and some commentary) on the current state of affairs in COA development/evaluation/use with a focus on one aspect: How do you know you are measuring the right thing? In the psychometric literature, this concept is referred to broadly as validity and has itself evolved over many years of research and application.